Would pan-tuberculosis treatment regimens be cost-effective?

Lancet Respir Med. 2018 Jul;6(7):486-488. doi: 10.1016/S2213-2600(18)30197-8. Epub 2018 May 31.

¹ 1550 Orleans Street, Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD 21230, USA. Electronic address: [email protected].
² The International Union Against TB and Lung Disease, Geneva, Switzerland.
³ Global TB Programme, World Health Organization, Geneva, Switzerland; Unité Mixte Internationale TransVIHMI (UMI 233 IRD - U1175 INSERM - Université de Montpellier), Institut de Recherche pour le Développement (IRD), Montpellier, France.
⁴ Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

No abstract available

Publication types